We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Santaris Delivers Six LNA-Based RNA Inhibitors to Enzon Ahead of Schedule

Santaris announces completion of the delivery of six cancer target drug candidates to its collaboration partner Enzon.
News

MCG Participating in National Study to Identify Genetic Variants in Schizophrenia

Study will examine the genes of 10,000 patients with schizophrenia and 10,000 healthy individuals in an effort to improve disease diagnosis and treatment.
News

"Plug and Play" Comes to Synthetic Biology

Howard researchers have developed a strategy for generating plug-and-play components for synthetic genetic networks that may nudge algae to create biofuels.
News

BioFocus DPI to Apply TET Technology in High-Throughput Screening Campaigns

The agreement will apply TET System's inducible gene technology in high-throughput screening campaigns performed for BioFocus DPI customers.
News

Cellectricon and BioFocus DPI Advance High Throughput ion Channel Drug Discovery

BioFocus DPI to utilize Cellectricon's Dynaflow®HT to further increase its electrophysiology-based screening capacity for fast ligand-gated ion channels.
News

febit Receives European Patent for Gene Extraction Procedure

The new patent refers to a technology used for a novel method directed at the selection and enrichment of DNA for re-sequencing purposes.
News

InteRNA and Radboud University to Develop microRNA-based Therapeutics for Prostate Cancer

InteRNA's lentiviral-based miRNA overexpression library will be used to identify the biological role of individual miRNAs and therapeutic targets.
News

QIAGEN and CNCI to Establish Cervical Cancer Screening Program in Kolkata

The initiative will be conducted over 5 years and is expected to reach 50,000 women.
News

Researchers Discover Potential Functional Role of Genetic Variation in Prostate Cancer Risk

The study uncovered how a small change in the DNA of the gene impacts the biology of prostate cancer risk.
News

SEQUENOM Announces Cost Cutting Initiative in Genetic Analysis Business

Company implements cost cutting initiatives to ensure the GA unit remains financially strong and approaches cash flow break-even.
Advertisement